Companies / Cytokinetics Inc / Activity
Activity — Cytokinetics Inc
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Blum Robert I CEO | Sell | Common Stock | $1.49M | -24K -5.27% | 430,330 0.31% of shares | medium |
| Mar 17, 2026 | Blum Robert I CEO | Sell | Common Stock | $787.6K | -13K -2.71% | 454,258 0.33% of shares | medium |
| May 14, 2026 | Blum Robert I CEO | Sell | Common Stock | $584.4K | -8K -1.84% | 400,330 0.29% of shares | medium |
| May 27, 2026 | Blum Robert I CEO | Sell | Common Stock | $579.1K | -8K -1.87% | 392,830 0.28% of shares | medium |
| Jun 15, 2026 | Blum Robert I CEO | Sell | Common Stock | $528.5K | -8K -1.91% | 385,330 0.28% of shares | medium |
| Apr 1, 2026 | Blum Robert I CEO | Sell | Common Stock | $499.7K | -8K -1.74% | 422,830 0.30% of shares | medium |
| Apr 15, 2026 | Blum Robert I CEO | Sell | Common Stock | $490.4K | -8K -1.77% | 415,330 0.30% of shares | medium |
| Mar 9, 2026 | Blum Robert I CEO | Sell | Common Stock | $481.6K | -8K -1.98% | 391,673 0.28% of shares | medium |
| Apr 29, 2026 | Blum Robert I CEO | Sell | Common Stock | $447.1K | -8K -1.81% | 407,830 0.29% of shares | medium |
| Mar 15, 2026 | Blum Robert I CEO | Grant | Common Stock | $0 | +75K +19.21% | 466,931 0.34% of shares | low |
| Mar 15, 2026 | Blum Robert I CEO | Grant | Non-Qualified Stock Option (Right to Buy) | — | +112K | 111,864 0.08% of shares | low |
| Mar 15, 2026 | Blum Robert I CEO | Grant | Incentive Stock Option (Right to Buy) | — | +2K | 1,665 <0.01% of shares | low |